The case pertains to the dissolution of Neocortex Life Sciences Private Limited under Section 54(1) of the Insolvency and Bankruptcy Code, 2016, following a liquidation process.
Corporate Debtor (CD) was admitted into CIRP on 13.02.2024.
The Applicant was appointed as the Interim Resolution Professional (IRP).
The Applicant filed an IA for liquidation of the CD as it did not possess substantial assets.
The Tribunal directed liquidation of the CD on 22.07.2025 and appointed the Applicant as Liquidator.
Public announcement was made inviting stakeholders to submit claims, but no claim was received during liquidation.
A Stakeholders Consultation Committee (SCC) was constituted, but none of the members attended any meetings.
The Liquidator identified book-value assets, but the realisable asset value was NIL.
A total sum of ₹68,405 was realised from the CD's bank accounts.
…Sign in to view the parties.
Corporate Debtor was…
Tribunal directed…
Sign in to view related legal provisions.
The case pertains to the dissolution of Neocortex Life Sciences Private Limited under Section 54(1) of the Insolvency and Bankruptcy Code, 2016, following a liquidation process.
Corporate Debtor (CD) was admitted into CIRP on 13.02.2024.
The Applicant was appointed as the Interim Resolution Professional (IRP).
The Applicant filed an IA for liquidation of the CD as it did not possess substantial assets.
The Tribunal directed liquidation of the CD on 22.07.2025 and appointed the Applicant as Liquidator.
Public announcement was made inviting stakeholders to submit claims, but no claim was received during liquidation.
A Stakeholders Consultation Committee (SCC) was constituted, but none of the members attended any meetings.
The Liquidator identified book-value assets, but the realisable asset value was NIL.
A total sum of ₹68,405 was realised from the CD's bank accounts.
…Corporate Debtor was…
Tribunal directed…
Sign in to view related legal provisions.